Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
iQure Pharma Inc. logo — Providing attractive therapies to patients and physicians wh...

iQure Pharma Inc.

Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors

Founded 2019 United States Princeton, United States 7 employees Debt Financing Total: $2.17M Biotechnology, Health and Wellness +1

General Information

Company Name iQure Pharma Inc.
Founded Year 2019
Location United States Princeton, United States
Employees 7
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with iQure Pharma Inc.. To contact iQure Pharma Inc., visit iqurepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does iQure Pharma Inc. compare?

A PDF of iQure Pharma Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting iQure Pharma Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About iQure Pharma Inc.

is a biotechnology and pharmaceutical startup based in the United States, founded in 2019. The company's slogan "Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors" encapsulates its mission. iQure Pharma is focused on developing new therapeutic solutions by leveraging academic research and industry expertise. The company's core competencies include scouting for innovative compounds from academic research, evaluating out-licensing opportunities with big pharma and biotech, and selecting compounds with significant attractive target profiles for commercialization. Additionally, iQure Pharma is dedicated to driving preclinical and clinical development activities while ensuring regulatory and quality compliance. In October 11, 2023, iQure Pharma secured a $1.20M Venture Round investment from Ventura BioMed Investors and OKG Capital. This investment signifies the confidence that these investors have in iQure Pharma's potential for delivering impactful therapies and generating attractive returns. With its unique positioning and focus on bridging academia and industry, iQure Pharma holds promise for both patients and investors seeking meaningful healthcare innovations and sustainable financial growth.

Business keywords: pharmaceutical research, technology transfer, out-licensing, biotech partnerships, clinical development, regulatory compliance, investment placement, commercialization, patient-centered, financial analysis, therapeutics evaluation, academic collaborations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $220.00K -
05 Apr 2024
Venture Round $1.20M 2
Ventura BioMed Investors
Ventura BioMed Investors, OKG Capital
11 Oct 2023
Grant Undisclosed 1
National Institutes of Health
31 Aug 2022
Series A $600.00K 3
Keiretsu Forum Northwest Keiretsu Forum - MidAtlantic
Keiretsu Forum Northwest, Keiretsu Forum - MidAtlantic +1
31 Aug 2022
Convertible Note $100.00K 1
Beat Widler
14 Sep 2020
Convertible Note $50.00K -
25 May 2020

iQure Pharma Inc. Alternatives & Competitors

View All Alternatives
iQure Pharma Inc. vs
APEIRON Biologics AG
APEIRON Biologics AG Austria

Improving the lives of patients with next generation therapies for cancer and respiratory disease, i...

Corporate Round
8 employees
Biotechnology, Health and Wellness
iQure Pharma Inc. vs
Ajinomoto Cambrooke, Inc.
Ajinomoto Cambrooke, Inc. United States

Leaders in Therapeutic Medical Nutrition

Series C
98 employees
Biotechnology, Health Care
iQure Pharma Inc. vs
Molecular Partners
Molecular Partners Switzerland

Pioneering DARPin Therapeutics for Patients

Post-IPO Equity
174 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About iQure Pharma Inc.

Providing attractive therapies to patients and physicians while ensuring significant return on investment for investors
iQure Pharma Inc. was founded in 2019.
iQure Pharma Inc. is headquartered in Princeton, United States.
iQure Pharma Inc. operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on pharmaceutical research, technology transfer, out-licensing and biotech partnerships.
iQure Pharma Inc. has approximately 7 employees.
iQure Pharma Inc. has completed 6 funding rounds, raising a total of $2.17M. The latest funding stage is Debt Financing.
Top alternatives and competitors to iQure Pharma Inc. include APEIRON Biologics AG, Ajinomoto Cambrooke, Inc., Molecular Partners, Mission Therapeutics, NuVision Biotherapies Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iQure Pharma Inc. and APEIRON Biologics AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for iQure Pharma Inc., https://bouncewatch.com/company/iqure-pharma-inc, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout